nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.721	1	CbGbCtD
Cidofovir—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0367	0.362	CbGpPWpGaD
Cidofovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0171	0.168	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—APRT—nephrolithiasis	0.0109	0.108	CbGpPWpGaD
Cidofovir—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0055	0.031	CcSEcCtD
Cidofovir—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0254	CcSEcCtD
Cidofovir—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.0226	CcSEcCtD
Cidofovir—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00357	0.0201	CcSEcCtD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00343	0.0337	CbGpPWpGaD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00318	0.0314	CbGpPWpGaD
Cidofovir—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00312	0.0176	CcSEcCtD
Cidofovir—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00302	0.017	CcSEcCtD
Cidofovir—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00295	0.0166	CcSEcCtD
Cidofovir—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00284	0.016	CcSEcCtD
Cidofovir—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00273	0.0154	CcSEcCtD
Cidofovir—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00272	0.0153	CcSEcCtD
Cidofovir—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00264	0.0149	CcSEcCtD
Cidofovir—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00262	0.0148	CcSEcCtD
Cidofovir—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00239	0.0135	CcSEcCtD
Cidofovir—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00233	0.0131	CcSEcCtD
Cidofovir—Injury—Hydrochlorothiazide—nephrolithiasis	0.00229	0.0129	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00225	0.0221	CbGpPWpGaD
Cidofovir—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00223	0.0126	CcSEcCtD
Cidofovir—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00221	0.0124	CcSEcCtD
Cidofovir—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0119	CcSEcCtD
Cidofovir—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0021	0.0118	CcSEcCtD
Cidofovir—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00208	0.0118	CcSEcCtD
Cidofovir—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0117	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00205	0.0202	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00205	0.0202	CbGpPWpGaD
Cidofovir—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0114	CcSEcCtD
Cidofovir—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00198	0.0111	CcSEcCtD
Cidofovir—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00197	0.0111	CcSEcCtD
Cidofovir—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0109	CcSEcCtD
Cidofovir—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00192	0.0108	CcSEcCtD
Cidofovir—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0108	CcSEcCtD
Cidofovir—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00189	0.0107	CcSEcCtD
Cidofovir—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00186	0.0105	CcSEcCtD
Cidofovir—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00185	0.0104	CcSEcCtD
Cidofovir—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00185	0.0104	CcSEcCtD
Cidofovir—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00182	0.0102	CcSEcCtD
Cidofovir—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00178	0.01	CcSEcCtD
Cidofovir—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00957	CcSEcCtD
Cidofovir—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00957	CcSEcCtD
Cidofovir—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00946	CcSEcCtD
Cidofovir—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00166	0.00934	CcSEcCtD
Cidofovir—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00932	CcSEcCtD
Cidofovir—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00923	CcSEcCtD
Cidofovir—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00918	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00905	CcSEcCtD
Cidofovir—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00897	CcSEcCtD
Cidofovir—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00895	CcSEcCtD
Cidofovir—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0089	CcSEcCtD
Cidofovir—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00887	CcSEcCtD
Cidofovir—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00887	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00156	0.0153	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00156	0.0153	CbGpPWpGaD
Cidofovir—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00155	0.00875	CcSEcCtD
Cidofovir—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0087	CcSEcCtD
Cidofovir—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00861	CcSEcCtD
Cidofovir—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00856	CcSEcCtD
Cidofovir—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00821	CcSEcCtD
Cidofovir—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00145	0.00819	CcSEcCtD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00145	0.0143	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00145	0.0143	CbGpPWpGaD
Cidofovir—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00813	CcSEcCtD
Cidofovir—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00807	CcSEcCtD
Cidofovir—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0079	CcSEcCtD
Cidofovir—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00775	CcSEcCtD
Cidofovir—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00764	CcSEcCtD
Cidofovir—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0076	CcSEcCtD
Cidofovir—TYMP—Metabolism—GRHPR—nephrolithiasis	0.00131	0.0129	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00129	0.0127	CbGpPWpGaD
Cidofovir—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00724	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00128	0.0126	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00128	0.0126	CbGpPWpGaD
Cidofovir—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00703	CcSEcCtD
Cidofovir—Tension—Hydrochlorothiazide—nephrolithiasis	0.00124	0.007	CcSEcCtD
Cidofovir—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00698	CcSEcCtD
Cidofovir—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00693	CcSEcCtD
Cidofovir—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00122	0.0069	CcSEcCtD
Cidofovir—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00122	0.00686	CcSEcCtD
Cidofovir—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00668	CcSEcCtD
Cidofovir—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00117	0.00662	CcSEcCtD
Cidofovir—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00117	0.00659	CcSEcCtD
Cidofovir—TYMP—Metabolism—AGXT—nephrolithiasis	0.00117	0.0115	CbGpPWpGaD
Cidofovir—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00655	CcSEcCtD
Cidofovir—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00116	0.00652	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00114	0.0112	CbGpPWpGaD
Cidofovir—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00643	CcSEcCtD
Cidofovir—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00641	CcSEcCtD
Cidofovir—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0064	CcSEcCtD
Cidofovir—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00638	CcSEcCtD
Cidofovir—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00627	CcSEcCtD
Cidofovir—Cough—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00622	CcSEcCtD
Cidofovir—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00607	CcSEcCtD
Cidofovir—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00607	CcSEcCtD
Cidofovir—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00607	CcSEcCtD
Cidofovir—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00605	CcSEcCtD
Cidofovir—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00106	0.006	CcSEcCtD
Cidofovir—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00594	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00104	0.0103	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00104	0.0103	CbGpPWpGaD
Cidofovir—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00587	CcSEcCtD
Cidofovir—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00582	CcSEcCtD
Cidofovir—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00582	CcSEcCtD
Cidofovir—Shock—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00573	CcSEcCtD
Cidofovir—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00101	0.0057	CcSEcCtD
Cidofovir—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00101	0.00568	CcSEcCtD
Cidofovir—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000998	0.00563	CcSEcCtD
Cidofovir—TYMP—Metabolism—APRT—nephrolithiasis	0.000994	0.00979	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC26A1—nephrolithiasis	0.000994	0.00979	CbGpPWpGaD
Cidofovir—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000984	0.00555	CcSEcCtD
Cidofovir—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000965	0.00544	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000941	0.0053	CcSEcCtD
Cidofovir—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000934	0.00527	CcSEcCtD
Cidofovir—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000927	0.00523	CcSEcCtD
Cidofovir—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00092	0.00519	CcSEcCtD
Cidofovir—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000918	0.00518	CcSEcCtD
Cidofovir—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000909	0.00512	CcSEcCtD
Cidofovir—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000897	0.00506	CcSEcCtD
Cidofovir—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00498	CcSEcCtD
Cidofovir—Pain—Hydrochlorothiazide—nephrolithiasis	0.000883	0.00498	CcSEcCtD
Cidofovir—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000851	0.0048	CcSEcCtD
Cidofovir—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000844	0.00476	CcSEcCtD
Cidofovir—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00082	0.00462	CcSEcCtD
Cidofovir—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000816	0.0046	CcSEcCtD
Cidofovir—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000816	0.0046	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000791	0.00779	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000791	0.00779	CbGpPWpGaD
Cidofovir—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000761	0.00429	CcSEcCtD
Cidofovir—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000741	0.00418	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000735	0.00724	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000735	0.00724	CbGpPWpGaD
Cidofovir—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00073	0.00412	CcSEcCtD
Cidofovir—TYMP—Metabolism—AQP1—nephrolithiasis	0.000708	0.00698	CbGpPWpGaD
Cidofovir—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00398	CcSEcCtD
Cidofovir—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000683	0.00385	CcSEcCtD
Cidofovir—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000656	0.0037	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000655	0.00646	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000655	0.00646	CbGpPWpGaD
Cidofovir—Rash—Hydrochlorothiazide—nephrolithiasis	0.000651	0.00367	CcSEcCtD
Cidofovir—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00065	0.00367	CcSEcCtD
Cidofovir—Headache—Hydrochlorothiazide—nephrolithiasis	0.000647	0.00365	CcSEcCtD
Cidofovir—TYMP—Metabolism—CHRM3—nephrolithiasis	0.00064	0.00631	CbGpPWpGaD
Cidofovir—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000613	0.00346	CcSEcCtD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000524	0.00516	CbGpPWpGaD
